Integrated Community Musculoskeletal and Pain Service

A Contract Addendum Notice
by NHS MID AND SOUTH ESSEX INTEGRATED CARE BOARD

Source: Find a Tender
Type: Contract (Services)
Duration: 5 year (est.)
Value: ___

Sector: HEALTH
Published: 19 Dec 2025
Delivery: 01 Feb 2026 to 31 Jan 2031 (est.)
Deadline: n/a

Related Terms

Location

Basildon

Geochart for 1 buyers and 0 suppliers

1 buyer

NHS Mid & South Essex Integrated Care Board Basildon

Description

This is a Corrigendum relating to the Contract Notice reference 2025/S 000-058719, that communicates NHS Mid and South Essex Integrated Care Board 's award of a public contract for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. This Corrigendum amends the Intention to Award Notice to an Award Notice. Please see II.2.4) Description of the procurement for further details.

Ammendments to Previous Notice

2. Section II II.1.4) Short description

This is a Contract Award Notice (Intention to Award) communicating NHS Mid and South Essex Integrated Care Board 's intention to Board's award of a public contract for provision of an Integrated Community Musculoskeletal and Pain Service (the Service), in accordance with the steps laid out in regulation 11 of the Health Care Services (Provider Selection Regime) Regulations 2023. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034.

3. Section II II.2.4) Description of the procurement

The Authority has undertaken a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the Regulations) and intends to award has awarded the Proposed Contract for a new Integrated Community Musculoskeletal and Pain Service (the Service) to the Preferred Bidder identified through the process, Cora Health MSK Limited. Working with stakeholders since 2023, the Authority has developed a new community pathway for people aged 16 years+, based on the East of England Musculoskeletal (MSK) Pathway Improvement Framework, the Best MSK high impact recommendations and adhering to the Getting It Right First Time (GIRFT) pathway. This new model of care intends to provide integration across patient pathways, including Single Point of Access (SPoA), clinical triage, physiotherapy, orthopaedics, spinal, rheumatology, pain management, surgical interventions and therapies across MSE. It will assess and treat more patients outside of acute services and deliver improved outcomes, quality and patient experience of care. Estimated dates between which the service is intended to be provided: The Proposed Contract duration is five years from 1st February 2026 until 31st January 2031, with an option to extend for a further three years beyond the initial term, until 31st January 2034. Approximate lifetime value of the contract: At the point of publication of the PIN, the Authority proposed a cost and volume financial model (local prices) in line with national guidance. The potential aggregate contract value (incl. extension term, growth/inflation assumptions, and potential variations) was £164,149,073 (excluding VAT). The financial envelope which acted as an affordability cap for the purposes of the competitive process was £90,163,317 based on the initial 5-year contract term. The Proposed Contract for the first five years has been awarded at £84,392,517.55. The Proposed Contract to be entered into by the Authority and the Preferred Bidder and a back to back version thereof with its proposed Sub-Contractor (both of which are existing providers of MSK Services in mid and south Essex), will be based on the NHS Standard Contract 2025/26 (full-length) and all subsequent variations thereof from time to time during the contract term.

4. Section VI VI.4.3) Review procedure

The standstill period requirements, including for review of decisions, are detailed in Regulations 12 and 14(3). Representations should be made by midnight on 2nd October latest. Provision for independent expert advice is set out in Regulation 23, including how the Independent Patient Choice and Procurement Panel may provide advice during the standstill period. Where Representations are received by 2ns October, initial reviews will be undertaken by the Authority via an appropriate internal governance mechanism that has been established to deal with representations made against provider selection decisions. The Authority will follow the relevant transparency requirements for the approach they take and will keep internal records of their decision-making. Where a provider(s) requests a further review by the Independent Patient Choice and Procurement Panel (within 5 working days of the Authority' publication of its it's Further Decision) they should seek relevant advice via the contact details provided herein at VI.4.4.